Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7

Oncotarget

Volumn 7, Issue 11, 2016, Pages 12163-12175

  Silva, Susana L ^a,b   Albuquerque, Adriana S ^a   Serra Caetano, Ana ^a   Foxall, Russell B ^a   Pires, Ana R ^a   Matoso, Paula ^a   Fernandes, Susana M ^a,b   Ferreira, João ^a   Cheynier, Rémi ^c   Victorino, Rui M M ^a,b   Caramalho, Iris ^a   Barata, João T ^a   Sousa, Ana E ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUT COCHIN   (France)

Author keywords

Human regulatory T cells; IL 7; Immune response; Immunity; Immunology and microbiology section; Na ve regulatory T cells; Regulatory T cell homeostasis; Thymectomy

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; FORKHEAD TRANSCRIPTION FACTOR; IL7 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; STEADY STATE; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; ADULT; CYTOLOGY; IMMUNOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-7; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84962891343     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7512     Document Type: Article

References (45)

1. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009; 30:899-911.
2. Liston A and Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol. 2014; 14:154-165.
3. Caramalho I, Nunes-Cabaco H, Foxall RB and Sousa AE. Regulatory T-Cell Development in the Human Thymus. Front Immunol. 2015; 6:395.
4. Booth NJ, McQuaid AJ, Sobande T, Kissane S, Agius E, Jackson SE, Salmon M, Falciani F, Yong K, Rustin MH, Akbar AN and Vukmanovic-Stejic M. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol. 2010; 184:4317-4326.
5. Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, Lee S, Nanan R and Fazekas de Saint Groth B. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood. 2006; 107:2830-2838.
6. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS and Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest. 2005; 115:1953-1962.
7. Caramalho I, Nunes-Silva V, Pires AR, Mota C, Pinto AI, Nunes-Cabaco H, Foxall RB and Sousa AE. Human regulatory T-cell development is dictated by Interleukin-2 and-15 expressed in a non-overlapping pattern in the thymus. J Autoimmun. 2015; 56:98-110.
8. Smigiel KS, Richards E, Srivastava S, Thomas KR, Dudda JC, Klonowski KD and Campbell DJ. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J Exp Med. 2014; 211:121-136.
9. Bains I, Antia R, Callard R and Yates AJ. Quantifying the development of the peripheral naive CD4+ T-cell pool in humans. Blood. 2009; 113:5480-5487.
10. den Braber I, Mugwagwa T, Vrisekoop N, Westera L, Mogling R, de Boer AB, Willems N, Schrijver EH, Spierenburg G, Gaiser K, Mul E, Otto SA, Ruiter AF, Ackermans MT, Miedema F, Borghans JA, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity. 2012; 36:288-297.
11. Sauce D, Larsen M, Fastenackels S, Duperrier A, Keller M, Grubeck-Loebenstein B, Ferrand C, Debre P, Sidi D and Appay V. Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest. 2009; 119:3070-3078.
12. Prelog M, Keller M, Geiger R, Brandstatter A, Wurzner R, Schweigmann U, Zlamy M, Zimmerhackl LB and Grubeck-Loebenstein B. Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life. Clin Immunol. 2009; 130:123-132.
13. Halnon NJ, Cooper P, Chen DY, Boechat MI and Uittenbogaart CH. Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis. Clin Dev Immunol. 2011; 2011:915864.
14. Sauce D, Larsen M, Fastenackels S, Roux A, Gorochov G, Katlama C, Sidi D, Sibony-Prat J and Appay V. Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults. J Immunol. 2012; 189:5541-5548.
15. Schadenberg AW, van den Broek T, Siemelink MA, Algra SO, de Jong PR, Jansen NJ, Prakken BJ and van Wijk F. Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy. J Allergy Clin Immunol. 2014; 133:277-280 e271-276.
16. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A and Thiel A. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002; 195:789-794.
17. Azevedo RI, Soares MV, Barata JT, Tendeiro R, Serra-Caetano A, Victorino RM and Sousa AE. IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner. Blood. 2009; 113:2999-3007.
18. Heninger AK, Theil A, Wilhelm C, Petzold C, Huebel N, Kretschmer K, Bonifacio E and Monti P. IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J Immunol. 2012; 189:5649-5658.
19. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE and Park JH. An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol. 2012; 188:5859-5866.
20. Younas M, Hue S, Lacabaratz C, Guguin A, Wiedemann A, Surenaud M, Beq S, Croughs T, Lelievre JD and Levy Y. IL-7 modulates in vitro and in vivo human memory T regulatory cell functions through the CD39/ATP axis. J Immunol. 2013; 191:3161-3168.
21. Simonetta F, Gestermann N, Martinet KZ, Boniotto M, Tissieres P, Seddon B and Bourgeois C. Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis. PLoS One. 2012; 7:e36596.
22. Schmaler M, Broggi MA, Lagarde N, Stocklin BF, King CG, Finke D and Rossi SW. IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice. Proc Natl Acad Sci U S A. 2015; 112:13330-13335.
23. van Gent R, Schadenberg AW, Otto SA, Nievelstein RA, Sieswerda GT, Haas F, Miedema F, Tesselaar K, Jansen NJ and Borghans JA. Long-term restoration of the human T-cell compartment after thymectomy during infancy: a role for thymic regeneration? Blood. 2011; 118:627-634.
24. Dion ML, Sekaly RP and Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol. 2007; 380:197-213.
25. Himmel ME, MacDonald KG, Garcia RV, Steiner TS and Levings MK. Helios+ and Helios-cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol. 2013; 190:2001-2008.
26. Dupont G, Demaret J, Venet F, Malergue F, Malcus C, Poitevin-Later F, Morel J and Monneret G. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3-cells versus regulatory T cells: a whole blood perspective. Cytokine. 2014; 69:146-149.
27. Bugault F, Benati D, Mouthon L, Landires I, Rohrlich P, Pestre V, Theze J, Lortholary O and Chakrabarti LA. Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia. PLoS One. 2013; 8:e55570.
28. Matsuoka K, Koreth J, Kim HT, Bascug G, McDonough S, Kawano Y, Murase K, Cutler C, Ho VT, Alyea EP, Armand P, Blazar BR, Antin JH, Soiffer RJ and Ritz J. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci Transl Med. 2013; 5:179ra143.
29. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL and Singer A. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity. 2004; 21:289-302.
30. Nunes-Cabaco H, Caramalho I, Sepulveda N and Sousa AE. Differentiation of human thymic regulatory T cells at the double positive stage. Eur J Immunol. 2011; 41:3604-3614.
31. Dooms H. Interleukin-7: Fuel for the autoimmune attack. J Autoimmun. 2013; 45:40-48.
32. Levine AG, Arvey A, Jin W and Rudensky AY. Continuous requirement for the TCR in regulatory T cell function. Nat Immunol. 2014; 15:1070-1078.
33. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA and Fauci AS. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol. 2008; 181:6738-6746.
34. Topalian SL, Drake CG and Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015; 27:450-461.
35. Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K, Battaglia CA, Landay AL, Pahwa S, Fischl MA, Asmuth DM, Tenorio AR, Altman JD, Fox L, Moir S, Malaspina A, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009; 113:6304-6314.
36. Perales MA, Goldberg JD, Yuan J, Koehne G, Lechner L, Papadopoulos EB, Young JW, Jakubowski AA, Zaidi B, Gallardo H, Liu C, Rasalan T, Wolchok JD, Croughs T, Morre M, Devlin SM, et al. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 2012; 120:4882-4891.
37. Levy Y, Sereti I, Tambussi G, Routy JP, Lelievre JD, Delfraissy JF, Molina JM, Fischl M, Goujard C, Rodriguez B, Rouzioux C, Avettand-Fenoel V, Croughs T, Beq S, Morre M, Poulin JF, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis. 2012; 55:291-300.
38. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med. 2008; 205:1701-1714.
39. Rosenberg SA, Sportes C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler-Stevenson M, Morton KE, Mavroukakis SA, Morre M, Buffet R, Mackall CL and Gress RE. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother. 2006; 29:313-319.
40. Weiss L, Letimier FA, Carriere M, Maiella S, Donkova-Petrini V, Targat B, Benecke A, Rogge L and Levy Y. In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients. Proc Natl Acad Sci U S A. 2010; 107:10632-10637.
41. Bell CJ, Sun Y, Nowak UM, Clark J, Howlett S, Pekalski ML, Yang X, Ast O, Waldhauer I, Freimoser-Grundschober A, Moessner E, Umana P, Klein C, Hosse RJ, Wicker LS and Peterson LB. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015; 56:66-80.
42. Albuquerque AS, Cortesao CS, Foxall RB, Soares RS, Victorino RM and Sousa AE. Rate of increase in circulating IL-7 and loss of IL-7Ralpha expression differ in HIV-1 and HIV-2 infections: two lymphopenic diseases with similar hyperimmune activation but distinct outcomes. J Immunol. 2007; 178:3252-3259.
43. Foxall RB, Albuquerque AS, Soares RS, Baptista AP, Cavaleiro R, Tendeiro R, Gomes P, Victorino RM and Sousa AE. Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia. AIDS. 2011; 25:1961-1970.
44. Albuquerque AS, Marques JG, Silva SL, Ligeiro D, Devlin BH, Dutrieux J, Cheynier R, Pignata C, Victorino RM, Markert ML and Sousa AE. Human FOXN1-deficiency is associated with alphabeta double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation. PLoS One. 2012; 7:e37042.
45. Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM and Sousa AE. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy. Clin Exp Allergy. 2008; 38:291-297.